Docebo launches US$70M share buyback offer
Docebo Inc. has approved a substantial issuer bid to repurchase for cancellation up to US$70,000,000 of common shares at US$20.40 per share, representing about 13.8% of shares outstanding on a non-diluted basis.
Rhea-AI Filing Summary
Docebo Inc. has approved a substantial issuer bid to repurchase for cancellation up to US$70,000,000 of common shares at US$20.40 per share, representing about 13.8% of shares outstanding on a non-diluted basis. The offer is not subject to a minimum tender condition; if tenders exceed the cap, shares will be taken up pro rata, with odd-lot holders (under 100 shares) exempt from proration.
The company intends to fund the bid with approximately US$10,000,000 of cash on hand and an approximately US$60,000,000 draw on its credit facility, which was recently increased to US$150,000,000. Controlling shareholder Intercap, which beneficially owns about 63.9% of outstanding shares, plans to participate in a way that maintains at least its current ownership percentage. Docebo has temporarily suspended purchases under its normal course issuer bid and also released preliminary unaudited Q2 2026 results and updated Q3 and full-year 2026 guidance, including outlooks for revenue, Annual Recurring Revenue and Adjusted EBITDA.
Positive
- None.
Negative
- None.
Filing Explained
The bid is approved but not yet commenced; formal terms are due July 21, while Q2 figures remain preliminary until the August 7 report.
The
The formal offer documents are expected to be filed with regulators and mailed to shareholders on or about
For a shareholder who sells under the offer, Docebo says the sale is generally expected to be treated as a dividend equal to the purchase price above the paid-up capital, which it estimates at approximately
The preliminary Q2 estimates remain subject to management, Audit Committee, closing-procedure and auditor review; final Q2 results are expected before the market opens on
Key Figures
Key Terms
substantial issuer bid regulatory
odd lot financial
normal course issuer bid regulatory
paid-up capital financial
Adjusted EBITDA financial
Annual Recurring Revenue financial
FAQ
What is Docebo (DCBO) offering in its substantial issuer bid?
What percentage of Docebo (DCBO) does Intercap own and how will it participate?
What other capital return program has Docebo (DCBO) adjusted because of the offer?
What financial information did Docebo (DCBO) release alongside the issuer bid?
AI-generated analysis. How Rhea-AI works. Not financial advice.